- Home
- NKTR vs LNKB Comparison
NKTR vs LNKB Comparison
Compare NKTR & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- LNKB
- Stock Information
- Founded
- NKTR 1990
- LNKB 2018
- Country
- NKTR United States
- LNKB United States
- Employees
- NKTR N/A
- LNKB N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- LNKB
- Sector
- NKTR Health Care
- LNKB
- Exchange
- NKTR Nasdaq
- LNKB Nasdaq
- Market Cap
- NKTR 247.9M
- LNKB 284.4M
- IPO Year
- NKTR 1994
- LNKB N/A
- Fundamental
- Price
- NKTR $0.93
- LNKB $7.43
- Analyst Decision
- NKTR Buy
- LNKB Hold
- Analyst Count
- NKTR 3
- LNKB 1
- Target Price
- NKTR $4.00
- LNKB $7.50
- AVG Volume (30 Days)
- NKTR 2.3M
- LNKB 78.0K
- Earning Date
- NKTR 11-07-2024
- LNKB 01-27-2025
- Dividend Yield
- NKTR N/A
- LNKB 3.89%
- EPS Growth
- NKTR N/A
- LNKB 61.51
- EPS
- NKTR N/A
- LNKB 0.17
- Revenue
- NKTR $93,137,000.00
- LNKB $86,138,000.00
- Revenue This Year
- NKTR $12.85
- LNKB N/A
- Revenue Next Year
- NKTR N/A
- LNKB $9.49
- P/E Ratio
- NKTR N/A
- LNKB $45.98
- Revenue Growth
- NKTR 5.53
- LNKB 151.51
- 52 Week Low
- NKTR $0.47
- LNKB $5.86
- 52 Week High
- NKTR $1.93
- LNKB $8.29
- Technical
- Relative Strength Index (RSI)
- NKTR 33.04
- LNKB 50.19
- Support Level
- NKTR $0.89
- LNKB $7.40
- Resistance Level
- NKTR $1.04
- LNKB $7.89
- Average True Range (ATR)
- NKTR 0.07
- LNKB 0.21
- MACD
- NKTR -0.00
- LNKB -0.05
- Stochastic Oscillator
- NKTR 14.81
- LNKB 17.24
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.